Table 2 1 H nuclear magnetic resonance (NMR) data of the antimicrobial fractions: 1 H NMR data obtained in methanol-d (CD 3 OD) at 500 MHz from the antimicrobial fractions (a) S14–2 (stearidonic acid) and (b) S14–3 (gamma-linolenic acid) from reverse-phase, high-performance liquid chromatographic separation
(a) | (b) | ||||
|---|---|---|---|---|---|
1H | Peak label on 1H-NMR spectrum | 1H | Peak label on 1H-NMR spectrum | ||
C1 | - | - | C1 | - | - |
C2 | 2.27, t, 2H | e | C2 | 2.24–2.26, t, 2H | e |
C3 | 1.61, m, 2H | c | C3 | 1.57–1.60, m, 2H | c |
C4 | 1.41, m, 2H | b | C4 | 1.32, m, 2H | b |
C5 | 2.08–2.10, m, 2H | d | C5 | 2.04–2.09, m, 2H | d |
C6 | 5.34–5.36, m, 1H | g | C6 | 5.32–5.34, m, 1H | g |
C7 | 5.34–5.36, m, 1H | g | C7 | 5.32–5.34, m, 1H | g |
C8 | 2.81–2.83, m, 2H | f | C8 | 2.78–2.84, m, 2H | f |
C9 | 5.34–5.36, m, 1H | g | C9 | 5.32–5.34, m, 1H | g |
C10 | 5.34–5.36, m, 1H | g | C10 | 5.32–5.34, m, 1H | g |
C11 | 2.81–2.83, m, 2H | f | C11 | 2.78–2.84, m, 2H | f |
C12 | 5.34–5.36, m, 1H | g | C12 | 5.32–5.34, m, 1H | g |
C13 | 5.34–5.36, m, 1H | g | C13 | 5.32–5.34, m, 1H | g |
C14 | 2.81–2.83, m, 2H | f | C14 | 2.04–2.09, m, 2H | d |
C15 | 5.34–5.36, m, 1H | g | C15 | 1.32, m, 2H | b |
C16 | 5.34–5.36, m, 1H | g | C16 | 1.32, m, 2H | b |
C17 | 2.08–2.10, m, 2H | d | C17 | 1.32, m, 2H | b |
C18 | 0.97, t, 3H | a | C18 | 0.96, t, 3H | a |